8-K - C4 Therapeutics, Inc. - 5.03 / 9.01
Filed: 2026-04-10 AccNo: 0001628280-26-024583 Size: 421 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Filed: 2026-04-10 AccNo: 0001628280-26-024583 Size: 421 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Filed: 2026-04-09 AccNo: 0001628280-26-024336 Size: 4 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits